FDA moves to increase availability of generic medications – UPI.com
June 28 (UPI) — The U.S. Food and Drug Administration has taken two new steps to provide more lower-cost prescription drug alternatives and increase competition.
As part of the FDA’s Drug Competition Action Plan rolled out in May, the agency on Tuesday published a list of off-patent, off-exclusivity branded drugs without approved generics and implemented a new policy to expedite the review of generic drug applications in places where competition is limited.
The agency plans to expedite the review of any generic drug application for a product on the list to allow them to come to market as quickly as possible.
The FDA said it will expedite the review of generic drug applications until there are three approved generics for a given drug on the market.
FAIR USE STATEMENT
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. The Uncensored Report (“the site”) is making such material available in an effort to further understanding of political, social, economic, and scientific issues, etc. The site asserts this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law.